Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models

Joshua A. Sonnen, John C. Breitner, Mark A. Lovell, William R. Markesbery, Joseph Quinn, Thomas J. Montine

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Advances in our understanding of the etiologies and pathogenesis of Alzheimer's disease (AD) highlight a role for free radical-mediated injury to brain regions from early stages of this illness. Here we will review the evidence from transgenic mouse models of AD, autopsy samples, and human biofluids obtained during life paying particular attention to the stage of disease. In addition, we will review the epidemiologic literature that addresses the potential of anti-oxidants to prevent incident dementia from AD, and the clinical trial literature that addresses anti-oxidant preventative or therapeutic strategies for different stage of AD. Future efforts in preclinical models and ultimately clinical trials are needed to define optimally effective agents and combinations, doses, and timing to suppress safely this facet of AD.

Original languageEnglish (US)
Pages (from-to)219-230
Number of pages12
JournalFree Radical Biology and Medicine
Volume45
Issue number3
DOIs
StatePublished - Aug 1 2008

Fingerprint

Transgenic Mice
Free Radicals
Brain
Alzheimer Disease
Oxidants
Clinical Trials
Brain Injuries
Dementia
Autopsy
Therapeutics

Keywords

  • Alzheimer's disease
  • Anti-oxidants
  • Mild Cognitive Impairement
  • Oxidative damage

ASJC Scopus subject areas

  • Medicine(all)
  • Toxicology
  • Clinical Biochemistry

Cite this

Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. / Sonnen, Joshua A.; Breitner, John C.; Lovell, Mark A.; Markesbery, William R.; Quinn, Joseph; Montine, Thomas J.

In: Free Radical Biology and Medicine, Vol. 45, No. 3, 01.08.2008, p. 219-230.

Research output: Contribution to journalArticle

Sonnen, Joshua A. ; Breitner, John C. ; Lovell, Mark A. ; Markesbery, William R. ; Quinn, Joseph ; Montine, Thomas J. / Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. In: Free Radical Biology and Medicine. 2008 ; Vol. 45, No. 3. pp. 219-230.
@article{d415aaee2269453bb699c8a3822effea,
title = "Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models",
abstract = "Advances in our understanding of the etiologies and pathogenesis of Alzheimer's disease (AD) highlight a role for free radical-mediated injury to brain regions from early stages of this illness. Here we will review the evidence from transgenic mouse models of AD, autopsy samples, and human biofluids obtained during life paying particular attention to the stage of disease. In addition, we will review the epidemiologic literature that addresses the potential of anti-oxidants to prevent incident dementia from AD, and the clinical trial literature that addresses anti-oxidant preventative or therapeutic strategies for different stage of AD. Future efforts in preclinical models and ultimately clinical trials are needed to define optimally effective agents and combinations, doses, and timing to suppress safely this facet of AD.",
keywords = "Alzheimer's disease, Anti-oxidants, Mild Cognitive Impairement, Oxidative damage",
author = "Sonnen, {Joshua A.} and Breitner, {John C.} and Lovell, {Mark A.} and Markesbery, {William R.} and Joseph Quinn and Montine, {Thomas J.}",
year = "2008",
month = "8",
day = "1",
doi = "10.1016/j.freeradbiomed.2008.04.022",
language = "English (US)",
volume = "45",
pages = "219--230",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models

AU - Sonnen, Joshua A.

AU - Breitner, John C.

AU - Lovell, Mark A.

AU - Markesbery, William R.

AU - Quinn, Joseph

AU - Montine, Thomas J.

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Advances in our understanding of the etiologies and pathogenesis of Alzheimer's disease (AD) highlight a role for free radical-mediated injury to brain regions from early stages of this illness. Here we will review the evidence from transgenic mouse models of AD, autopsy samples, and human biofluids obtained during life paying particular attention to the stage of disease. In addition, we will review the epidemiologic literature that addresses the potential of anti-oxidants to prevent incident dementia from AD, and the clinical trial literature that addresses anti-oxidant preventative or therapeutic strategies for different stage of AD. Future efforts in preclinical models and ultimately clinical trials are needed to define optimally effective agents and combinations, doses, and timing to suppress safely this facet of AD.

AB - Advances in our understanding of the etiologies and pathogenesis of Alzheimer's disease (AD) highlight a role for free radical-mediated injury to brain regions from early stages of this illness. Here we will review the evidence from transgenic mouse models of AD, autopsy samples, and human biofluids obtained during life paying particular attention to the stage of disease. In addition, we will review the epidemiologic literature that addresses the potential of anti-oxidants to prevent incident dementia from AD, and the clinical trial literature that addresses anti-oxidant preventative or therapeutic strategies for different stage of AD. Future efforts in preclinical models and ultimately clinical trials are needed to define optimally effective agents and combinations, doses, and timing to suppress safely this facet of AD.

KW - Alzheimer's disease

KW - Anti-oxidants

KW - Mild Cognitive Impairement

KW - Oxidative damage

UR - http://www.scopus.com/inward/record.url?scp=46449119069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46449119069&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2008.04.022

DO - 10.1016/j.freeradbiomed.2008.04.022

M3 - Article

C2 - 18482592

AN - SCOPUS:46449119069

VL - 45

SP - 219

EP - 230

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 3

ER -